R&D | April 29, 2026
Evonik and Higuchi launch “Open Pharma Lab” in Yokohama to accelerate oral drug Innovation
EUDRAGIT polymers remain a cornerstone technology in oral drug delivery
EUDRAGIT polymers remain a cornerstone technology in oral drug delivery
The approval was driven by data from the Phase III TULIP-SC trial
Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
Arcot is a seasoned executive with more than two decades of experience across the global pharma and life sciences sectors
CDSCO-cleared BSM-5700 series targets ICU, NICU, ER, OR and digital health integration under ABDM
Subscribe To Our Newsletter & Stay Updated
